Clin Mol Hepatol.
2021 Apr;27(2):281-282. 10.3350/cmh.2021.0072.
Another oral antiviral treatment, but still far away from hepatitis B virus cure
- Tseng TC
1,2,3
- Affiliations
-
- 1Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
- 2Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
- 3Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan
- KMID: 2514769
- DOI: http://doi.org/10.3350/cmh.2021.0072
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The mechanism and treatment of anti-viral resistant hepatitis B virus
- Core protein inhibitors: Opportunities and challenges at the forefront of hepatitis B cure: Editorial on “Phase 1 trial of the safety, pharmacokinetics, and antiviral activity of EDP-514 in untreated viremic chronic hepatitis B patients”
- Application of CRISPR/Cas9 in Treating Hepatitis B Virus
- Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus
- Hepatitis C Virus and Antiviral Drug Resistance
